EDIT vs IT
Editas Medicine Inc (EDIT) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
EDIT currently screens at market cap $375.2M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the EDIT and IT stock pages for the full models.
Not investment advice.